Glow Lifetech Corp. (GLOW.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.64 Million CAD | 29.73% |
| 2022 | -2.29 Million CAD | 56.5% |
| 2021 | -5.27 Million CAD | -3338.66% |
| 2020 | -153.47 Thousand CAD | 16.03% |
| 2019 | -182.77 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -257.78 Thousand CAD | 48.64% |
| 2024 Q2 | -244.86 Thousand CAD | -3.63% |
| 2023 Q1 | -313.61 Thousand CAD | 65.03% |
| 2023 FY | -1.61 Million CAD | 29.73% |
| 2023 Q4 | -501.88 Thousand CAD | -37.45% |
| 2023 Q3 | -365.12 Thousand CAD | 7.62% |
| 2023 Q2 | -395.23 Thousand CAD | -26.02% |
| 2022 Q2 | -502.66 Thousand CAD | 19.48% |
| 2022 FY | -2.29 Million CAD | 56.5% |
| 2022 Q1 | -624.26 Thousand CAD | -20.95% |
| 2022 Q4 | -896.93 Thousand CAD | -246.11% |
| 2022 Q3 | -259.15 Thousand CAD | 48.45% |
| 2021 Q4 | -516.13 Thousand CAD | -12.71% |
| 2021 FY | -5.27 Million CAD | -3338.66% |
| 2021 Q1 | -3.13 Million CAD | -31584.66% |
| 2021 Q2 | -1.16 Million CAD | 62.74% |
| 2021 Q3 | -457.93 Thousand CAD | 60.8% |
| 2020 FY | -153.47 Thousand CAD | 16.03% |
| 2020 Q4 | 9958.00 CAD | 111.68% |
| 2020 Q3 | -85.27 Thousand CAD | -119.42% |
| 2020 Q2 | -38.86 Thousand CAD | 1.13% |
| 2020 Q1 | -39.3 Thousand CAD | 20.82% |
| 2019 Q4 | -49.63 Thousand CAD | -40.29% |
| 2019 Q2 | -76.16 Thousand CAD | -252.87% |
| 2019 Q3 | -35.38 Thousand CAD | 53.55% |
| 2019 Q1 | -21.58 Thousand CAD | 0.0% |
| 2019 FY | -182.77 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 67.264% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 78.725% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 49.303% |
| BioVaxys Technology Corp. | -2.4 Million CAD | 31.628% |
| ChitogenX Inc. | -2.83 Million CAD | 41.954% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 56.063% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 87.02% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | -423.17% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 67.701% |
| Lexston Life Sciences Corp. | -674.71 Thousand CAD | -143.466% |
| Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | -115.31% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | -335.002% |
| MYND Life Sciences Inc. | -1.8 Million CAD | 9.131% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -36.631% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 46.036% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | -70.561% |
| Telescope Innovations Corp. | -5.76 Million CAD | 71.514% |